ライフサイエンスコーパス: nasogastric tube

1 r 5 days or placebo was administered through nasogastric tube.

2 -sided CDH and 14 with right-sided CDH-had a nasogastric tube.

3 d mucosal damage, either orally or through a nasogastric tube.

4 newborns, at the time of routine changing of nasogastric tubes.

5 c gastrostomy tubes compared with those with nasogastric tubes (20.3% vs. 40.7%, respectively; p = .0

6 rievable coil-shaped LA-DAAS compatible with nasogastric tube administration and the capacity to enca

7 receive 80 mg of simvastatin (42 donors) via nasogastric tube after declaration of brain death and up

8 r more days or the need for reinsertion of a nasogastric tube after starting oral diet in the absence

9 that selective, rather than routine, use of nasogastric tubes after abdominal surgery (2 meta-analys

10 casein and whey protein were collected by a nasogastric tube and protein degradation and peptide rel

11 They are more comfortable than nasogastric tubes and may be kept in place for several m

12 The positions of nasogastric tubes and umbilical venous catheters vary in

13 eadmission, ileus (defined as reinsertion of nasogastric tube), and intra-abdominal infection and ass

14 (two 40-mg doses on day 1, via orogastric or nasogastric tube, and 40 mg each day thereafter) or intr

15 rred during passage of the bougie dilator or nasogastric tube, and two occurred after surgery seconda

16 ered the presence of bright red blood in the nasogastric tube as failure of SUP.

17 ium was administered orally or by means of a nasogastric tube as part of a routine protocol for CT ev

18 need to handle stool" and "receiving FMT by nasogastric tube" as most unappealing.

19 Sertraline was administered orally or via nasogastric tube at a dose of 400 mg/day for 2 weeks, fo

20 to be independent predictors of a prolonged nasogastric tube dependence.

21 low-fat elemental-like diet administered by nasogastric tube during severe pancreatitis does not wor

22 Any use of oxygen therapy, nasogastric-tube feeding, or ventilatory support was rec

23 ngth of stay, use of oxygen supplementation, nasogastric-tube feeding, ventilatory support, and relat

24 evelop recommendations concerning the use of nasogastric tubes, Foley catheters, and central lines.

25 razole suspension was administered through a nasogastric tube, followed by 5 to 10 mL of tap water.

26 used to determine the appropriate length of nasogastric tube for optimal placement in adults.

27 Donor fecal infusion via nasogastric tube, gastroscope or colonoscope in children

28 ted no difference between groups (60% in the nasogastric tube group and 80% in the colonoscopy group;

29 des, fecal infusion either rectally or via a nasogastric tube has become a viable option for the trea

30 e allocated to receive 33 mL (or 25 mL via a nasogastric tube if a participant's swallowing was impai

31 Misplacement of the nasogastric tube in the respiratory tract could cause se

32 All nasogastric tubes in the 14 patients with right-sided CD

33 Nasogastric tube insertion rates were higher after TORS

34 Preplanned outcome measures included nasogastric tube insertion rates within 4 weeks after su

35 etric capnometry or capnography in detecting nasogastric tubes located in the airway and differentiat

36 onsidered an effective approach to determine nasogastric tube location, there is a paucity of up-to-d

37 unrelated donors, comparing colonoscopic and nasogastric tube (NGT) administration.

38 e usage of this equipment in the guidance of nasogastric tube (NGT) insertion.

39 ent (ED) visit/hospitalization rate, time to nasogastric tube (NGT) removal, rate of discharge with a

40 ective intra-abdominal surgeries requiring a nasogastric tube (NGT) was conducted.

41 and two or more vomiting episodes per day or nasogastric tube (NGT) who were previously treated with

42 itamin D3 or placebo was given orally or via nasogastric tube once at a dose of 540,000 IU followed b

43 perforations due to foreign body insertion (nasogastric tube or pulling through of percutaneous endo

44 surgery [odds ratio (OR) = 1], presence of a nasogastric tube (OR = 1.6), intraoperative blood transf

45 st 30 min after a meal every 8 h (or 6 h via nasogastric tube) over 24 h for 28 days.

46 ical leak, return to the operating room, and nasogastric tube placement (a surrogate for ileus).

47 d in differentiating between respiratory and nasogastric tube placement for critically ill adult pati

48 en inadvertent airway intubation and correct nasogastric tube placement in any adult care setting.

49 acute hepatic failure, prolonged duration of nasogastric tube placement, alcoholism, and an increased

50 city for the detection of inadvertent airway nasogastric tube placements in critically ill adults.

51 stics examined included age, sex, concurrent nasogastric tube presence, primary diagnosis, Acute Phys

52 ence in risk of anastomotic leak, pneumonia, nasogastric tube reinsertion, reoperation, readmission,

53 ze outcomes of anastomotic leaks, pneumonia, nasogastric tube reinsertion, reoperation, readmissions,

54 ly mobilization, incentive spirometry, early nasogastric tube removal, alvimopan usage, and judicious

55 A nasogastric tube should only be placed for symptomatic r

56 ed colectomy, treatment with any antibiotic, nasogastric tube suction, advanced age, and prior antibi

57 Subjects were equipped with a double-lumen nasogastric tube that migrated to the proximal jejunum.

58 Converting nasogastric tubes to percutaneous endoscopic gastrostomy

59 In the PEG versus nasogastric tube trial, 321 patients were enrolled by 47

60 in 71 neonates with CDH to determine whether nasogastric tubes, umbilical venous catheters, and umbil

61 Improper placement of nasogastric tube used for feeding may lead to serious co

62 Thus, nasogastric tube verification is necessary for optimal p

63 The nasogastric tube was clamped for 1 to 2 hrs after each a

64 In 13 patients, the tip of the nasogastric tube was lodged at the esophagogastric junct

65 rolled trial of its kind, fecal infusion via nasogastric tube was shown to be beneficial in treating

66 A nasogastric tube was used for oral rehydration in 126 of

67 e who received enteral nutrition through the nasogastric tube were excluded from enrollment.

68 site, postoperative comorbidity, stoma, and nasogastric tube) with LRD patients having an adjusted 1